Development of the national Expected Screening Rate for cardiovascular disease, type 2 diabetes, cervical cancer and colorectal cancer as a benchmark for Canadians.

Ma, Irene; Guo, Maggie; Naugler, Christopher T.

Objective: To provide a benchmark for the percentage of patients that would be expected to be screened each year on a population basis if physicians were following current Canadian screening guidelines for cardiovascular disease (CVD), type 2 diabetes, cervical cancer, and colorectal cancer. Methods: An Internet search was used to obtain the most recent Canadian screening guideline for each disease, which was then used as a reference. The estimated screening rate (ESR) was then calculated by determining the percentage of Canadian population that should be targeted or excluded from screening using Internet searches of the Canadian federal government or not-for-profit organization databases, or peer-reviewed literatures. For the two chronic diseases (CVD, type 2 diabetes), the ESR was calculated by: Sum (target populations from the risk groups/number of years between screenings). The ESR for the two cancers (cervical, colorectal) was calculated by: (100% of the target population - x% of the excluded population)/number of years between screenings. Data and Results: The table below summarizes the results of the expected screening rates in Canada. Conclusions: This benchmark can be used to guide any jurisdiction in Canada to assess the adequacy of disease screening on a population level.

CARDIOVASCULAR diseases; TYPE 2 diabetes; CERVICAL cancer; COLON cancer; CHRONIC diseases

Canadian Journal of Pathology, 2017, Vol 9, p15

1918-915X

Academic Journal